Operating as a standalone business has empowered the organization to meet rapidly evolving customer needs and industry standards. KiddeFenwal, the global leader in the fire...
The environmental consultant and leading developer of bioremediation of groundwater contaminants has landed in the top five of the same category for six consecutive years....
Pioneering 140,000 square-foot facility will anchor Cyclic Materials’ recycling infrastructure, combining commercial-scale processing and R&D to advance a secure, circular supply chain for rare earths...
NitroFix, an Israeli climate tech startup pioneering decentralized green ammonia production, and 1s1 Energy, a California-based developer of advanced electrochemical systems, have been awarded a Binational Industrial Research and Development...
Addition of industry leaders as COO and Director of Business Development will help biomaterials company meet rising demand for its MacroLink™ and SuperCrude™ solutions Biomaterials...
TriLink BioTechnologies, a Maravai® LifeSciences company and global provider of life science reagents and services, and the International Vaccine Institute (IVI), a non-profit international organization...
Today NBE Therapeutics (NBE) a wholly owned subsidiary of Boehringer Ingelheim, officially opened its new ADC R&D facility in Basel. This milestone reinforces its commitment to innovation in oncology and strengthens its footprint in Switzerland’s biotech ecosystem. NBE Therapeutics, a Swiss biotech founded in 2012 that...
500 Homes Expected to be Powered by this Community Solar Project SolarBank Corporation (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: GY2) (“SolarBank” or the “Company”) is pleased to announce...
Breakthrough Will Support Development of New Circulation Cell Culture System to Enhance Quality and Stability of Manufacturing PHC Corporation (Headquarters: Chiyoda-ku, Tokyo; President: Nobuaki Nakamura;...
Murata Manufacturing Co., Ltd. (TOKYO: 6981) (ISIN: JP3914400001) announced today that has successfully commercialized and mass produced “CELLNETTA,” the world’s first*1 metal cell fractionation filter designed...
Celltrion today announced that the European Commission (EC) has granted marketing authorization for three products across two biosimilars: Eydenzelt® (CT-P42, aflibercept), a biosimilar to Eylea® to treat multiple...